Nucl Med Mol Imaging.
2009 Aug;43(4):301-308.
Usefulness of FDG-PET/CT as a Diagnostic Tool for Routine Post Therapy Evaluation in Endometrial Cancer
- Affiliations
-
- 1Department of Nuclear medicine, CHA Bundang Medical center, CHA University, Sungnam Korea. tjjeon66@hanmail.net
- 2Department of Gynecologic Oncology, CHA Bundang Medical center, CHA University, Sungnam Korea.
- 3Department of Radiology, CHA Bundang Medical center, CHA University, Sungnam Korea.
- 4Department of Pathology CHA Bundang Medical center, CHA University, Sungnam Korea.
Abstract
-
PURPOSE: The aim of this study was to evaluate the usefulness of FDG-PET/CT as follow up imaging tool in patients with endometrial cancer after therapy. Material and Methods: One hundred one patients with endometrial cancer who underwent FDG PET/CT after the treatment of this disease were included in this study population (25-79 yr old, Mean age 50.6 yr old) and all these patients also performed various laboratory and imaging studies such as serum tumor marker, CT or MRI. The lesions having increased focal FDG uptake were classified into benign, equivocal, and malignant one according to their pattern and activity. Tumor recurrence was confirmed by histopathological results and other clinical and imaging data.
RESULTS
Among the 19 patients with 30 malignant or equivocal hot uptakes, 11 of 14 patients supposed to be malignant finding in PET/CT were proved to be tumor recurrence, while one of 5 patients with equivocal lesions were recurred malignancy. Two false negative cases were turned out to be peritoneal carcinomatosis. Estimated sensitivity, specificity and accuracy of PET/CT for diagnosis of recurrence in endometrial carcinoma after treatment were 86 %, 92 % and 91%, respectively. Positive and negative predictive values in the same issue were 63% and 98%, respectively.
CONCLUSION
FDG-PET/CT is useful for regular work up of endometrial carcinoma after the treatment because of its high negative predictive value as well as high sensitivity and specificity.